Flexion Therapeutics Company Profile (NASDAQ:FLXN)

About Flexion Therapeutics

Flexion Therapeutics logoFlexion Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on the development and commercialization of therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis and post-operative pain. The Company's portfolio of product candidates addresses the OA pain treatment spectrum, from moderate to severe pain. The Company's lead product candidate, Zilretta (also known as FX006), is a late-stage, injectable, sustained-release, intra-articular (IA) steroid for patients with moderate to severe OA pain. The Company's other product candidates include FX007, a preclinical, small-molecule tropomyosin receptor kinase A (TrkA) receptor antagonist designed to address post-operative pain, and FX005, a sustained-release p38 mitogen-activated protein (MAP), kinase inhibitor for the treatment of end-stage OA patients. The Company has not generated any revenue.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: FLXN
  • CUSIP:
Key Metrics:
  • Previous Close: $18.02
  • 50 Day Moving Average: $17.13
  • 200 Day Moving Average: $13.90
  • 52-Week Range: $27,521,000.00 - $7.56
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -6.44
  • P/E Growth: 0.00
  • Market Cap: $495.93M
  • Outstanding Shares: 27,521,000
  • Beta: 1.5
Profitability:
  • Return on Equity: -48.17%
  • Return on Assets: -40.33%
Debt:
  • Debt-to-Equity Ratio: 0.09%
  • Current Ratio: 20.09%
  • Quick Ratio: 20.09%
Additional Links:
Companies Related to Flexion Therapeutics:

Analyst Ratings

Consensus Ratings for Flexion Therapeutics (NASDAQ:FLXN) (?)
Ratings Breakdown: 7 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $37.50 (108.10% upside)
Analysts' Ratings History for Flexion Therapeutics (NASDAQ:FLXN)
Show:
DateFirmActionRatingPrice TargetDetails
9/6/2016Lake Street CapitalReiterated RatingBuy$38.00View Rating Details
7/19/2016BMO Capital MarketsReiterated RatingBuyView Rating Details
6/30/2016Royal Bank Of CanadaReiterated RatingBuyView Rating Details
6/30/2016Wells Fargo & Co.Reiterated RatingBuyView Rating Details
7/1/2016Janney Montgomery ScottReiterated RatingBuy$30.00View Rating Details
5/27/2016Needham & Company LLCReiterated RatingBuy$28.00 -> $34.00View Rating Details
5/26/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details
9/2/2015Northland SecuritiesReiterated RatingBuy$40.00View Rating Details
3/30/2015MLV & Co.Initiated CoverageBuy$38.00View Rating Details
11/26/2014Summer StreetReiterated RatingBuyView Rating Details
(Data available from 9/26/2014 forward)

Earnings

Earnings History for Flexion Therapeutics (NASDAQ:FLXN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
8/3/2016Q2($0.67)($0.63)ViewN/AView Earnings Details
5/12/2016Q1($0.61)($0.78)ViewListenView Earnings Details
11/9/2015Q3($0.60)($0.52)ViewListenView Earnings Details
8/6/2015Q215($0.54)($0.58)ViewN/AView Earnings Details
5/7/2015Q115($0.56)($0.43)ViewN/AView Earnings Details
3/31/2015($0.46)($0.47)ViewN/AView Earnings Details
11/13/2014Q314($0.55)($0.45)ViewN/AView Earnings Details
8/7/2014($0.52)($0.38)ViewN/AView Earnings Details
5/9/2014($0.53)($0.86)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Flexion Therapeutics (NASDAQ:FLXN)
Current Year EPS Consensus Estimate: $-2.69 EPS
Next Year EPS Consensus Estimate: $-2.80 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.59)($0.59)($0.59)
Q3 20161($0.55)($0.55)($0.55)
Q4 20161($0.58)($0.58)($0.58)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Flexion Therapeutics (NASDAQ:FLXN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Flexion Therapeutics (NASDAQ:FLXN)
Insider Ownership Percentage: 18.00%
Institutional Ownership Percentage: 68.27%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/21/2016Samuel D ColellaDirectorBuy25,504$13.71$349,659.84View SEC Filing  
6/20/2016Samuel D ColellaDirectorBuy6,778$13.84$93,807.52View SEC Filing  
6/14/2016C Ann MerrifieldDirectorBuy1,000$13.39$13,390.00View SEC Filing  
6/8/2016Samuel D ColellaDirectorBuy714,285$14.00$9,999,990.00View SEC Filing  
5/20/2016Michael D ClaymanCEOBuy2,000$10.41$20,820.00View SEC Filing  
5/19/2016Michael D ClaymanCEOBuy2,000$9.65$19,300.00View SEC Filing  
5/19/2016Neil BodickInsiderBuy850$10.00$8,500.00View SEC Filing  
5/18/2016Michael D ClaymanCEOBuy2,000$10.23$20,460.00View SEC Filing  
5/18/2016Neil BodickInsiderBuy2,100$10.20$21,420.00View SEC Filing  
5/17/2016Frederick W DriscollCFOBuy2,500$9.87$24,675.00View SEC Filing  
5/17/2016Michael D ClaymanCEOBuy2,000$9.73$19,460.00View SEC Filing  
5/17/2016Neil BodickInsiderBuy800$9.60$7,680.00View SEC Filing  
5/16/2016Frederick W DriscollCFOBuy2,500$9.19$22,975.00View SEC Filing  
5/16/2016Michael D ClaymanCEOBuy2,000$9.51$19,020.00View SEC Filing  
5/16/2016Neil BodickInsiderBuy1,250$9.22$11,525.00View SEC Filing  
9/11/2015C Ann MerrifieldDirectorBuy1,000$23.00$23,000.00View SEC Filing  
6/22/2015A/S NovoMajor ShareholderSell150,000$20.61$3,091,500.00View SEC Filing  
3/16/2015Neil BodickInsiderSell4,000$25.28$101,120.00View SEC Filing  
3/10/2015Neil BodickInsiderSell4,000$24.26$97,040.00View SEC Filing  
3/4/2015Neil BodickInsiderSell4,000$23.45$93,800.00View SEC Filing  
2/26/2015Neil BodickInsiderSell4,000$22.44$89,760.00View SEC Filing  
12/17/2014A/S NovoMajor ShareholderBuy500,000$17.00$8,500,000.00View SEC Filing  
2/18/2014A/S NovoInsiderBuy692,308$13.00$9,000,004.00View SEC Filing  
2/18/2014Bradley J Phd BolzonDirectorBuy307,692$13.00$3,999,996.00View SEC Filing  
2/18/2014Sofinnova Partners SasMajor ShareholderBuy230,769$13.00$2,999,997.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Flexion Therapeutics (NASDAQ:FLXN)
DateHeadline
nasdaq.com logoNoteworthy Friday Option Activity: AWI, OMF, FLXN (NASDAQ:FLXN)
www.nasdaq.com - September 23 at 4:48 PM
News IconEarnings According to Analysts for Flexion Therapeutics, Inc. (NASDAQ:FLXN)? - Frisco Fastball (NASDAQ:FLXN)
friscofastball.com - September 21 at 5:34 PM
News IconFlexion Therapeutics Incorporated (NASDAQ:FLXN) Sellers Covered 0.42% of Their Shorts - Post News (NASDAQ:FLXN)
www.kentuckypostnews.com - September 19 at 3:58 PM
News IconStock Update: Estimates & Target in Focus for Flexion Therapeutics, Inc. (NASDAQ:FLXN) - Frisco Fastball (NASDAQ:FLXN)
friscofastball.com - September 15 at 8:04 AM
globenewswire.com logoFlexion Therapeutics Announces Appointment of Mark Stejbach to its Board of Directors - GlobeNewswire (press release) (NASDAQ:FLXN)
globenewswire.com - September 15 at 8:04 AM
4-traders.com logoFLEXION THERAPEUTICS INC : Change in Directors or Principal Officers (form 8-K) (NASDAQ:FLXN)
www.4-traders.com - September 14 at 5:05 PM
biz.yahoo.com logoFLEXION THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:FLXN)
biz.yahoo.com - September 14 at 5:05 PM
finance.yahoo.com logoFlexion Therapeutics Announces Appointment of Mark Stejbach to its Board of Directors - Yahoo Finance (NASDAQ:FLXN)
finance.yahoo.com - September 14 at 9:15 AM
publicnow.com logoFlexion Therapeutics Announces Appointment of Mark Stejbach to its Board of Directors (NASDAQ:FLXN)
www.publicnow.com - September 14 at 9:15 AM
globenewswire.com logoFlexion Therapeutics Announces Two Key Corporate Appointments - GlobeNewswire (press release) (NASDAQ:FLXN)
globenewswire.com - September 12 at 4:53 PM
publicnow.com logoFlexion Therapeutics Announces Two Key Corporate Appointments (NASDAQ:FLXN)
www.publicnow.com - September 12 at 9:53 AM
benzinga.com logoLake Street Capital Likes Felxion's Lead Drug Candidate, Prescribes A Buy Rating - Benzinga (NASDAQ:FLXN)
www.benzinga.com - September 8 at 8:54 AM
finance.yahoo.com logoFlexion Therapeutics to Present at 2016 Wells Fargo Healthcare Conference (NASDAQ:FLXN)
finance.yahoo.com - August 31 at 9:48 AM
finance.yahoo.com logoHow Flexion (FLXN) Stock Stands Out in a Strong Industry (NASDAQ:FLXN)
finance.yahoo.com - August 26 at 4:55 PM
finance.yahoo.com logoFLEXION THERAPEUTICS INC Financials (NASDAQ:FLXN)
finance.yahoo.com - August 11 at 5:16 PM
globenewswire.com logoFlexion Therapeutics Reports Second-Quarter 2016 Financial Results - GlobeNewswire (press release) (NASDAQ:FLXN)
globenewswire.com - August 4 at 5:20 PM
thestreet.com logoSeeing Some Good Action in Individual Stocks (NASDAQ:FLXN)
realmoney.thestreet.com - August 4 at 5:20 PM
globenewswire.com logoFlexion Therapeutics Reports Second-Quarter 2016 Financial ... - GlobeNewswire (press release) (NASDAQ:FLXN)
www.globenewswire.com - August 4 at 5:41 AM
finance.yahoo.com logoFlexion Therapeutics reports 2Q loss - Yahoo Finance (NASDAQ:FLXN)
finance.yahoo.com - August 4 at 5:41 AM
finance.yahoo.com logoEdited Transcript of FLXN earnings conference call or presentation 3-Aug-16 8:30pm GMT (NASDAQ:FLXN)
finance.yahoo.com - August 4 at 5:41 AM
twst.com logoFlexion Therapeutics Inc.: Flexion Therapeutics Reports Second-Quarter 2016 Financial Results (NASDAQ:FLXN)
www.twst.com - August 3 at 10:42 PM
nasdaq.com logoFlexion Therapeutics Reports Second-Quarter 2016 Financial Results (NASDAQ:FLXN)
www.nasdaq.com - August 3 at 5:20 PM
sg.finance.yahoo.com logoFlexion Therapeutics reports 2Q loss (NASDAQ:FLXN)
sg.finance.yahoo.com - August 3 at 5:20 PM
finance.yahoo.com logoFlexion Therapeutics (FLXN) Stock: Moving Average Crossover Alert (NASDAQ:FLXN)
finance.yahoo.com - July 29 at 6:31 AM
publicnow.com logoFlexion Therapeutics to Report Second-Quarter 2016 Financial Results on August 3, 2016 (NASDAQ:FLXN)
www.publicnow.com - July 25 at 8:18 AM
breakingfinancenews.com logoA report released today by Lake Street about Flexion Therapeutics(NASDAQ:FLXN) raises the target price to $38 (NASDAQ:FLXN)
breakingfinancenews.com - July 24 at 9:32 AM
finance.yahoo.com logoCoverage initiated on Flexion Therapeutics by Lake Street (NASDAQ:FLXN)
finance.yahoo.com - July 21 at 8:52 AM
News IconFlexion Therapeutics Incorporated (NASDAQ:FLXN) Shorted Shares Increased By 10.84% - Consumer Eagle (NASDAQ:FLXN)
www.consumereagle.com - July 21 at 8:34 AM
fiscalstandard.com logoBroker Outlook For Flexion Therapeutics Inc (FLXN) - Fiscal Standard (NASDAQ:FLXN)
www.fiscalstandard.com - July 20 at 6:22 PM
News IconShares Moving Down on the Week: Flexion Therapeutics, Inc. (NASDAQ:FLXN) - Engelwood Daily (NASDAQ:FLXN)
www.engelwooddaily.com - July 17 at 9:32 AM
News IconFlexion Therapeutics Incorporated (NASDAQ:FLXN) Shorted Shares Increased By 35.39% - Consumer Eagle (NASDAQ:FLXN)
www.consumereagle.com - July 14 at 10:22 PM
news.cmlviz.com logoFlexion Therapeutics Inc Realized Volatility Hits Extreme Level - CML News (NASDAQ:FLXN)
news.cmlviz.com - July 14 at 10:22 PM
News IconInstitutional Investors Are Buying Flexion Therapeutics Inc (NASDAQ:FLXN) - Consumer Eagle (NASDAQ:FLXN)
www.consumereagle.com - July 13 at 6:10 AM
fool.com logoBillionaires Are Piling Into These 3 Stocks (NASDAQ:FLXN)
www.fool.com - July 12 at 8:15 AM
News IconWere Analysts Bearish Flexion Therapeutics Inc (NASDAQ:FLXN) This Week? - Engelwood Daily (NASDAQ:FLXN)
www.engelwooddaily.com - July 10 at 9:31 AM
fiscalstandard.com logoNext Weeks Broker Price Targets For Flexion Therapeutics Inc (FLXN) - Fiscal Standard (NASDAQ:FLXN)
www.fiscalstandard.com - July 10 at 9:31 AM
fiscalstandard.com logoBrokers Issue Average Price Target Of 35.51 On Flexion Therapeutics Inc (FLXN) - Fiscal Standard (NASDAQ:FLXN)
www.fiscalstandard.com - July 8 at 5:01 PM
seekingalpha.com logoFlexion Therapeutics: Insider Buying Signals Attractive Opportunity - Seeking Alpha (NASDAQ:FLXN)
seekingalpha.com - July 8 at 5:01 PM
news.cmlviz.com logoFlexion Therapeutics, Inc. Stock Momentum Hits Strength - CML News (NASDAQ:FLXN)
news.cmlviz.com - July 8 at 6:17 AM
News IconTime to Buy Flexion Therapeutics Inc After Today's Huge Increase? - Engelwood Daily (NASDAQ:FLXN)
www.engelwooddaily.com - July 7 at 6:07 AM
News IconShares Heading Higher in Session: Flexion Therapeutics, Inc. (NASDAQ:FLXN) - Telanagana Press (NASDAQ:FLXN)
telanaganapress.com - July 6 at 10:50 PM
News IconFlexion Therapeutics Incorporated (NASDAQ:FLXN) Shorted Shares Increased 35.39% After Market Selling - Press Telegraph (NASDAQ:FLXN)
presstelegraph.com - July 6 at 5:07 PM
News IconBMO Capital Initiates Coverage on Flexion Therapeutics Inc to Outperform - TheFounders Daily (NASDAQ:FLXN)
www.thefoundersdaily.com - July 6 at 5:06 PM
247wallst.com logoWhy Flexion Therapeutics Is Adding 3 New Executives to Its Ranks - 24/7 Wall St. (NASDAQ:FLXN)
247wallst.com - July 6 at 5:06 PM
finance.yahoo.com logoWhy Flexion Therapeutics Is Adding 3 New Executives to Its Ranks (NASDAQ:FLXN)
finance.yahoo.com - July 6 at 11:10 AM
ftsenews.co.uk logoFlexion Therapeutics Inc (FLXN) Updated Price Targets - FTSE News (NASDAQ:FLXN)
www.ftsenews.co.uk - July 5 at 9:44 AM
News IconHow Analysts Rated Flexion Therapeutics Inc (NASDAQ:FLXN) Last Week? - Press Telegraph (NASDAQ:FLXN)
presstelegraph.com - July 2 at 4:55 PM
fiscalstandard.com logoRecently Issued Stock Ratings For Flexion Therapeutics Inc (FLXN) - Fiscal Standard (NASDAQ:FLXN)
www.fiscalstandard.com - July 1 at 6:28 AM
News IconCheck on Share Volatility: Flexion Therapeutics, Inc. (NASDAQ:FLXN) - Engelwood Daily (NASDAQ:FLXN)
www.engelwooddaily.com - June 28 at 10:00 PM
equities.com logoFlexion Therapeutics Inc. (FLXN) Jumps 5.57% on June 20 - Equities.com (NASDAQ:FLXN)
www.equities.com - June 22 at 9:43 AM

Social

Flexion Therapeutics (NASDAQ:FLXN) Chart for Monday, September, 26, 2016


Last Updated on 9/26/2016 by MarketBeat.com Staff